KUALA LUMPUR, July 2 (Bernama) -- CHAKRA WE CARE RESOURCES SDN BHD a renowned company in promoting wellness through nutritional supplements, nutraceutical has launched a new product IMMNU3 GCG (MAL20026102NCR) registered under The National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia (MOH) with patented ingredient aimed to increase the immune system in the body by triggering each cell to produce its own glutathione.
 
IMMNU3 GCG contains a blend ingredient, Immune Formulation 200®, a patented composition of amino acid blend namely the glycine, cysteine and glutamine which is the building block to produce glutathione added together with selenomethionine to enhance the absorption.  This new breakthrough technology in the blend was a brainchild of a Harvard graduate, US based, world renowned scientist, Professor Dr Albert B. Crum. This dietary supplement feeds your immune system in the manner nature is designed to utilize its elements in the body.
 
Glutathione as many may know or may not know is a protein molecule that is present in every cell and extremely important in boosting a stressed immune system. Many clinical trials were conducted and published in reputable journal on the benefits of glutathione in the body. Other benefits include a reduction in oxidative stress which is caused by an imbalance between the production of free radicals and the body’s inability to fight them off.
 
These days, most of our immune system is compromised due to our diet, lifestyle and environmental factor resulting in the deficiency of a life-saving molecule which is our master immune booster. Glutathione is also recognized in the medical literature as the master anti-oxidant and the master detoxifying agent. Our body’s immune, anti-oxidant & detoxification system are three important pillars of health that defends us from not only from infectious diseases but also non-infectious diseases.
 
IMMNU3 GCG is available in a powder form. This patented dietary supplement promotes immune support. Immune Formulation 200® is the 1.8-billion-dollar research product of ProImmune USA, LLC funded by NIH of USA. Sole Asia distributorship is given to a Malaysian company, Chakra We Care Resources Sdn Bhd which is promoting, IMMNU3 GCG through their subsidiary company Nu Heal 365 Sdn Bhd.

Source: CHAKRA WE CARE RESOURCES SDN. BHD.

FOR MORE INFORMATION, PLEASE CONTACT:
Name: Ms Yamuna
Tel: +603 7773 2299
Email: info@chakrawecare.com
 
--BERNAMA